Longer Read
Blurred lines: Where are the boundaries?
Where does the line fall between a professional relationship or a friendship with a patient? What are the pitfalls to avoid on social media? Megan Haggan looks into the difficult …
The link between acne and diet: where are we now?
Evidence continues to grow on the role diet plays in acne, with certain food types linked to exacerbations, while others may be beneficial. Jala Moushi reviews the research Acne is …
Fostering a healthy community: flu vaccines and advice
As established advocates and administrators of vaccination, pharmacists play a vital role in promoting and supporting flu vaccination uptake. By Leanne Philpott KEY POINTS: Influenza is an acute viral infection …
An age old problem
Communication – with patients, families and carers, as well as with other health professionals – is key when it comes to managing pain in older people living in residential aged …
Covid: Has it really been so long?
It’s now been four years since the Covid-19 pandemic was declared. It has driven changes in pharmacy, as in so much of healthcare, and indeed society. Where are we currently …
Achoo: advice for navigating cough and cold season
The cough and cold category is the perfect opportunity to tailor treatment and self-care advice, differentiating the pharmacy from other retailers, writes Leanne Philpott KEY POINTS: Adults have on average …
No ‘golden ticket’ for reducing risky meds harm
High-risk prescribing in aged care residents under the spotlight, as Australian experts weigh in on the role of embedded pharmacists Polypharmacy and the use of potentially inappropriate medicines (PIMs) in …
Bringing menopause out of the shadows
The overwhelming list of symptoms, treatment choices, and misinformation can leave many patients muddled when it comes to menopause, writes Leanne Philpott Menopause isn’t ‘secret women’s business’—at least it shouldn’t …
Actions speak louder than words
Pharmacy owners need to see a “fair” Eighth Community Pharmacy Agreement signed before they will feel confident in future viability of the sector While industry leaders are continuing to negotiate …
‘An exciting time’: a new era in treating migraine
New treatment options and changes to the scheduling of existing medicines are heralding changes to the outlook for patients who experience migraine, writes Megan Haggan “It’s an exciting time in …
Opioids, overdose and naloxone: starting the conversation
Risk factors for overdose are surprisingly common among patients taking prescribed opioids, but how can pharmacists best approach conversations around safety and prevention? Sheshtyn Paola investigates Most people know that …
